OMVs that express PD1 bind specifically to tumour cell membranes, resulting in PD-L1 internalisation and disruption of PD-L1-mediated immunosuppression, thereby promoting T-cell proliferation [104]. The gene discussed is RPL17; the disease is neoplasm.